serena williams on glp 1 Could Williams' GLP-1 Disclosure Shift Obesity Stigma? Serena Williams says weight loss

Quantifying ligand bias at seven-transmembrane receptors

However, patients should be advised to report symptoms suggestive of liver injury, including: Persistent nausea or vomiting unrelated to expected GI side effects Right upper quadrant abdominal pain (which may also indicate gallbladder disease, a known risk with GLP-1 therapy) Jaundice (yellowing of skin or eyes) Dark urine or pale stools Unexplained fatigue or malaise Clinicians should maintain a low threshold for investigating these symptoms with comprehensive liver function tests, including ALT, AST, alkaline phosphatase, bilirubin, albumin, and INR/prothrombin time

Brand-name vs compounded: what you're actually buying The medication-source split is the most important non-price decision

Just show your member ID card at an in-network pharmacy to learn if you could save

This highlights that there could be more potential opportunities around positive allosteric modulation of the GLP-1 receptor

Target Indication Insights Why did the type 2 diabetes segment dominate the obesity GLP-1 market